The 1988 Nobel Prize in Physiology or Medicine was awarded to George H. Hitchings for his pioneering investigations into the chemical principles of drug treatment. His career marked a departure from traditional trial-and-error pharmacology, focusing instead on the biochemical differences between healthy cells and pathogens to develop targeted therapies for complex diseases.
Academic Foundation
Born in Hoquiam in 1905, George H. Hitchings moved through various locations including Berkeley, San Diego, and Seattle during his upbringing. He graduated from Franklin High School as salutatorian before attending the University of Washington. By 1927, he earned a chemistry degree, followed by a master's thesis focused on marine biology. He continued his academic trajectory at Harvard Medical School, completing his Ph.D. in 1933 while engaging in early research at the institution.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Research at Burroughs Wellcome
In 1942, Hitchings transitioned to the Wellcome Research Laboratories in Tuckahoe. A partnership with Gertrude Elion, which began in 1944, proved vital to his subsequent achievements. His team targeted the metabolic pathways of disease-causing agents, leading to the development of compounds like 2,6-diaminopurine and various folic acid antagonists. This systematic approach established a framework for creating drugs to treat leukemia, gout, and bacterial infections.
Clinical Applications and Legacy
The research programs led by Hitchings produced critical medications, including pyrimethamine for malaria, allopurinol for gout, and azathioprine for organ transplantation. His studies into biochemical inhibition also laid the groundwork for future antiviral treatments, notably acyclovir for herpes and zidovudine for AIDS. Beyond his industrial research, he served as a vice president at Burroughs-Wellcome and held adjunct professorships at Duke University, while also founding the Triangle Community Foundation.
Fast facts
- Born: 1905, Hoquiam, United States
- Died: 1998, Chapel Hill, United States
- Education: University of Washington, Harvard Medical School
- Primary Fields: Biochemistry, Pharmacology
- Nobel Prize: Physiology or Medicine, 1988
- Royal Society: Elected Foreign Member, 1974
- Key Institutional Affiliations: Duke University, Burroughs Wellcome & Company
Questions readers ask
What was the core contribution of Hitchings' research?
He pioneered methods for designing drugs that selectively target the biochemistry of pathogens or cancer cells without harming healthy tissue.
Which major medical conditions did his team’s drugs address?
His work contributed to therapies for leukemia, malaria, gout, bacterial infections, organ transplant rejection, herpes, and AIDS.
Achievements
- Nobel Prize in Physiology or Medicine — 1988
- Cameron Prize of the University of Edinburgh
- Held posts at Duke University, Case Western Reserve University and Burroughs Wellcome & Company
- Fields: biochemistry and pharmacology
